Purpose: The aim of this work was to quantify the extent of lipid-rich necrotic core (LRNC) and intraplaque hemorrhage (IPH) in atherosclerotic plaques. Methods: Patients scheduled for carotid endarterectomy underwent four-point Dixon and T1-weighted magnetic resonance imaging (MRI) at 3 Tesla. Fat and R2* maps were generated from the Dixon sequence at the acquired spatial resolution of 0.60 Â 0.60 Â 0.70 mm voxel size. MRI and threedimensional (3D) histology volumes of plaques were registered. The registration matrix was applied to segmentations denoting LRNC and IPH in 3D histology to split plaque volumes in regions with and without LRNC and IPH. Results: Five patients were included. Regarding volumes of LRNC identified by 3D histology, the average fat fraction by MRI was significantly higher inside LRNC than outside: 12.64 6 0.2737% versus 9.294 6 0.1762% (mean 6 standard error of the mean [SEM]; P < 0.001). The same was true for IPH identified by 3D histology, R2* inside versus outside IPH was: 71.81 6 1.276 s À1 versus 56.94 6 0.9095 s À1 (mean 6 SEM; P < 0.001). There was a strong correlation between the cumulative fat and the volume of LRNC from 3D histology (R 2 ¼ 0.92) as well as between cumulative R2* and IPH (R 2 ¼ 0.94). Conclusion: Quantitative mapping of fat and R2* from Dixon MRI reliably quantifies the extent of LRNC and IPH. Magn Reson Med 78:285-296,
INTRODUCTION
Decisions to intervene in atherosclerotic cardiovascular disease (CVD) are primarily based on stenosis severity. For example, patient selection for carotid endarterectomy (CEA) relies on the presence of symptoms indicative of cerebral ischemia and the degree of luminal narrowing caused by the carotid plaque (1) . However, there is increasing evidence that stenosis severity alone is not sufficient to determine stroke risk. It has been shown that patients at high risk for stroke, but without any measurable stenosis, have a high proportion of advanced plaques (2) . Furthermore, there is evidence that carotid plaque composition per se is a predictor of cardiovascular events (3) . Thus, assessing carotid plaque composition noninvasively would arguably improve risk assessment for cardiovascular events not only for stroke, but also throughout the entire arterial circulation.
Plaques at high risk for causing arterial thrombosis with subsequent ischemic necrosis are called vulnerable plaques. Arterial thrombosis is most often caused by rupture or erosion of a vulnerable plaque (4) . Established features of vulnerable plaques are lipid-rich necrotic core (LRNC), intraplaque hemorrhage (IPH), thin fibrous cap, and, to a lesser extent, plaque calcification (4) . Owing to its excellent soft tissue sensitivity, magnetic resonance imaging (MRI) has been used for carotid plaque characterization by multiple groups. Typically, blood-suppressed T 1 -weighted (T 1 W), T 2 -weighted (T 2 W), proton-density-weighted (PDW) fast-spin echo, gradient-echo, and time-of-flight sequences are used (5) . Using this multicontrast approach, different plaque components can be identified, based on their relative signal intensity compared to the signal intensity of surrounding muscle, typically the sternocleidomastoid (6) . Multicontrast MRI has been successfully used to characterize carotid plaques, it has been validated by histology in a number of studies (5) , and it offers stroke risk information beyond measurement of luminal narrowing in carotid atherosclerosis (7) .
Despite these advantages, there are limitations to multicontrast MRI of carotid plaque that prevent its widespread clinical application. One of these is that it relies on extensive postacquisition assessment of differences in image intensity. The nonquantitative nature of this assessment, its operator dependency, its reliance on multiple sequences, and the fact that the sequences are not entirely specific for the plaque components of interest present barriers to the adoption of multicontrast MRI in routine clinical practice. As mentioned above, for carotid plaque imaging, the sternocleidomastoid muscle is used as reference tissue. However, when the signal intensity from the adjacent muscle on fat-suppressed T 2 W images is too low for use as a standard reference, the submandibular and parotid glands have been used (8) . Ideally, the reference tissue should represent a uniform distribution of intensity values, independent of its location within the image volume, but, in reality, this is rarely the case. One of the biggest sources of intensity inhomogeneity is the surface coil used in carotid imaging, and numerous approaches have been proposed to correct this problem (9) . For example, all manufacturers use coil sensitivity maps acquired in separate reference scans to correct for intensity inhomogeneity, but because these maps only rescale to the homogeneity of integrated body coil, they do not necessarily provide a truly uniform homogeneity. Because of its proximity to the skin, intensity in images acquired from the sternocleidomastoid muscle is especially sensitive to the inhomogeneity caused by the sensitivity profile of surface coils. Thus, the issues with assessing plaque components, based on relative image intensity, emphasize the need for quantitative physical measurements of plaque constituents associated with vulnerability.
Regarding the validation of carotid plaque MRI, histology is the gold standard to determine plaque composition. Hence, validation of in vivo MRI is possible by mapping histological data to in vivo data. Most often, histology sections of the plaque are registered to in vivo images using the carotid bifurcation as a landmark (10) . Because of the difference in MRI slice thickness (mm) and the thickness of histology sections (mm), there is a risk of inaccurate registration, even when using an easily recognizable landmark such as the carotid bifurcation. This problem increases with increasing distance from the bifurcation. The need for accurate registration of MRI and histology is further emphasized by the fact that there is significant variation in plaque composition along the length of the plaque (11) . Adding to the complexity of registering two dimensional (2D) histology sections with MRI slices is the fact that out-of-plane angulations of the histology sections versus the MRI slices, as well as shrinkage and deformation during tissue processing, are routinely neglected (12) .
The goal of the current study was to develop a quantitative fat and R2* mapping technique to provide quantitative in vivo measurements of the extent of LRNC and IPH in carotid plaque. To this end, we used a fourpoint Dixon gradient-echo sequence to measure LRNC and extracted the R2* value to quantify IPH. Originally proposed by Dixon (13) , this gradient-echo sequence takes advantage of the slightly different resonance frequency of fat and water, which leads to constructive and destructive interference of signal when measuring at different echo times. Analysis of the resulting signal oscillations allows for the calculation of the quantity of both water and fat in the human body (13) . Simultaneously, signal is lost because of phase dispersion (the transverse T2* relaxation), which is increased by local magnetic field disturbances, for example, attributed to the presence of iron. Therefore, the rate of signal loss (R2* ¼ 1/T2*) in a carotid plaque can be viewed as a measure for the presence of (heme) iron and thus can be expected to correlate to the extent of IPH. Indeed, in a different context (i.e., MRI of the brain), R2* has been shown to correlate strongly and in a linear fashion with tissue iron content (14) . Additionally, to overcome the shortcomings related to validation of in vivo MRI with 2D histology, we validated the MRIbased quantification of LRNC and IPH by correlating the measurements with registered three-dimensional (3D) histology volumes of the plaques. A preliminary version of the current data was presented in poster format at the American Heart Association's Annual Scientific Sessions 2014 (15) .
METHODS
The study was approved by Link€ oping's Institutional Review Board (record no.: 2012/321-32). and written informed consent was obtained from all participants prior to study entry.
Patients
Patients were included in the study if they were scheduled for CEA. The indication for CEA was the presence of a high-grade (!70%) carotid artery stenosis with or without recent (<14 days) cerebrovascular ischemia in the form of stroke, transient ischemic attack, or amaurosis fugax. Stenosis severity was assessed by measuring peak systolic velocity from the Doppler signal acquired during ultrasound imaging of the carotid artery, according to criteria established in the European Carotid Surgery Trial (16) . All patients underwent MRI <24 hours before surgery.
MRI
We applied a four-point Dixon sequence at 3 Tesla to generate high-resolution maps of the fat percentage and values of R2* relaxation rate per voxel in atherosclerotic plaque. At 3T, the 3.3 parts per million frequency difference between water and fat creates an oscillating signal every 2.4 ms. Because of the limited gradient slew rate and strength needed to achieve sufficient resolution in the acquisition, we chose an out-of-phase, in-phase, out-ofphase, in-phase scheme at echo times (TEs) of multiples of 3.6 ms (hence at TE ¼ 3.6, 7.2, 10.8, and 14.4 ms). The water-fat shift was maximized at 1.3 pixels. It was assumed that all voxels exhibited a single, effective R2* relaxation rate. Proton density and T1 relaxation differences between water and fat were not taken into account. Hence, the signal magnitude S at each TE was modeled according to:
where W is the water fraction and F is the fat fraction. Water and fat percentages were calculated by division by the sum of the two. Other acquisition parameters for the sequence were repetition time (TR) ¼ 18 ms, turbo field echo (TFE) factor 12, and flip angle 10 . Field of view was 220 Â 220 Â 60 mm, centered on the flow divider at an isotropic acquisition resolution 0.75 mm, reconstructed at 0.60 mm. The acquisition used a Cartesian 3D readout where k-space filling was performed from the center outward (low-high, radial). The corners of k-space were not included, resulting in a cylindrical. Two regional saturation slabs of 80 mm were added inferior and superior to the acquisition volume, with a gap of 40 mm, to suppress inflowing blood signal. Using a TR ¼ 18 ms and TFE ¼ 12, these saturation bands were applied every 216 ms. Scan time was 9 minutes 45 seconds. Modeling and postprocessing was performed in an adapted version of SyMRI software (SyntheticMR, Linkping, Sweden) producing fat, water, and R2* maps at the acquired spatial resolution of 0.60 Â 0.60 Â 0.70 mm voxel size. The postprocessing time was 10 seconds.
In addition to the four-point Dixon acquisition, a T 1 W turbo-spin echo (TSE) acquisition was performed with TE ¼ 9 ms, TR ¼ 1 heart beat, and TSE factor 6. A blackblood pulse sequence was used with a delay of 430 ms. The acquisition resolution was 0.55 mm, reconstructed at 0.47 mm; 18 slices of 2.1 mm, no gap, were acquired.
All scans were acquired on a 3T Philips Ingenia system using a 20-channel HeadNeckSpine coil (Philips Healthcare, Best, The Netherlands). Figure 1 summarizes the tissue and image processing steps involved in the generation of the 3D histology volumes, image segmentation, and registration. Plaques were fixed in 10% formalin immediately after surgery, decalcified, embedded in paraffin, and trimmed at 50-mm intervals. At every 50-mm step, an image was taken of the plaque surface with the plaque positioned vertically in the paraffin block. Thus, these so called en face images represent cross-sectional views of the plaque. An example is shown in the upper bar of Figure 1 , to the right hand side of the caption "en face images from paraffin block." These images were taken using a fluorescent microscope with a mechanical stage using a 5 Â objective, taking advantage of the autofluorescence of the tissue (Imager.Z1 AxioCam MRm; Carl Zeiss, Jena, Germany). At every 200-mm step, a 5-mm-thick section was taken for morphometric assessment of LRNC and IPH (Fig. 2) . Areas containing amorphous material and cholesterol crystals were classified as LRNC. Sections were stained trichrome to detect red blood cells, and areas containing red blood cells were classified as IPH. Wholeslide digital imaging of stained sections was performed with bright-field microscopy using a 10 Â objective (Imager.Z1 AxioCam ERc 5s; Carl Zeiss).
3D Histology and Image Registration
En face images were used to generate the 3D backbone for subsequent registration with the histology sections. To this end, they were automatically registered to form a digital image stack using the StackReg plugin (17) within ImageJ 1.49 (National Institutes of Health [NIH], Bethesda, MD). This image stack was loaded into ITK-SNAP 2.2 (Penn Image Computing and Science Laboratory, University of Pennsylvania, Philadelphia, PA), to automatically create a segmented volume using a sparsefield-level set segmentation method (18, 19) . Next, the stained histology sections were manually registered to the corresponding en face image within ImageJ (NIH) using the interactive affine plugin, thus correcting for any deformations that might have occurred during sectioning and transfer onto the glass slide. The tissue expands when sectioned and transferred to the glass slide, and to quantify the extent of expansion, morphometric analysis was used in ImageJ (NIH), measuring the area of the en face image in the paraffin block and the Quantitative Mapping of Lipid Rich Necrotic Core and Intraplaque Hemorrhagearea of its corresponding trichrome-stained section on the slide. A stack of the histology sections was then generated, imported into ITK-SNAP, and 3D volumes of the LRNC and IPH were generated by manual segmentation. These volumes integrated the morphometric data on LRNC and IPH into the 3D backbone.
The resultant volumes and MRI data were imported into MeVisLab software (version 2.2.1; MeVis Medical Solutions AG, Bremen, Germany), where the T 1 W MRI was automatically registered to the water, fat, and R2* maps from the four-point Dixon sequence using the MERIT framework within MeVisLab (20) . MRI data were upsampled by a scale of 10, and 3D histology volume was manually registered with the T 1 W MRI by matching the lumen in the 3D histology volume with the lumen within the MRI throughout the volume (Fig. 4a) . Fresh sample shrinks during the processing steps that precede paraffin embedding and shrinkage was accounted for by manually stretching the 3D volume to match the lumen in the T 1 W image, thus achieving accurate registration of both volumes. To quantify the extent of shrinkage, morphometric analysis was performed using ImageJ (NIH), comparing the area of the en face image with the area of the plaque on the cranial surface of the corresponding T 1 W image slice. In addition, this registration step allowed for adjustment of the 3D histology volume to out-of-plane angulations in the MRI (Fig. 4b) . The resultant registration matrix was then applied to the segmentations denoting LRNC and IPH from 3D histology to split the plaque volume in regions with and without LRNC and IPH. For each of the resulting volumes (whole plaque, areas within LRNC, IPH, and areas outside LRNC and IPH), the fat and R2* values in each voxel were recorded.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism softtware (version 6.05; GraphPad Software, Inc., La Jolla, CA). An unpaired t test was used to analyze the differences between average MRI values per voxel within LRNC and IPH as defined by 3D histology versus the MRI values outside LRNC and IPH. These values are presented as a mean 6 standard error of the mean (SEM), and P values < 0.05 were considered statistically significant. Linear regression analysis was performed to study the relationship between the cumulative value of corresponding MRI measurements from each voxel throughout the plaque and the volume of LRNC and IPH from histology. To assess the mean difference between the MRI values and the corresponding histological data and the 95% limits of agreement between them, Bland-Altman plots were generated. To account for the fact that the difference between the methods increased as the magnitude of the measured values increased, the approximate proportionality between difference and magnitude of the measurements was addressed as recommended by Bland and Altman, by plotting the ratio of the MRI values versus the 3D histology values as a function of their average (21) .
RESULTS

Patients
A total of 8 patients consented to participate in the study. In 1 patient, the MRI was of insufficient quality because of bulk motion artefacts attributed to swallowing, and in 1 patient, the scan had to be aborted because of claustrophobia. Furthermore, in 1 patient, the plaque specimen was too fragmented to be able to generate a 3D histology volume. Thus, here we report on 5 patients with good-quality MRI and intact plaque specimens (Fig. 3) . In 4 patients, the stenosis was associated with recent cerebral ischemia, and in 1 patient, the stenosis was asymptomatic. The clinical characteristics, cardiovascular risk factors, comorbidity, and medication of these patients are summarized in Table 1 lesion classification system (22) . Registration of the histological sections to the 3D backbone showed that sectioning and positioning of the tissue on glass slides caused an expansion of the tissue by 15.4 6 4.1% (mean 6 standard deviation [SD]) relative to its dimensions in the paraffin block. The scaling factors used in registration of 3D histology to T 1 W MRI are shown in Supporting Table 1 . This registration revealed that average shrinkage of the plaque was 9.2 6 2.1% (mean 6 SD) relative to the situation in vivo. The out-of-plane angulations in each patient are shown in Figure 4b which shows that there are clear differences between the scanning direction in vivo and the vertical orientation of the tissue section in the paraffin block.
Validation of MRI by 3D Histology
After registration with 3D histology and segmentation of LRNC and IPH volumes based on the histology volumes, we were able to generate fat and R2* maps from Dixon imaging that gave us the fat fraction and R2* value for each voxel inside and outside the LRNC and IPH (Figs. 5  and 6 ). Figure 7 illustrates the fat fractions and the R2* values throughout each individual plaque. As is apparent from these data, the extent of LRNC and IPH varied considerably between plaques and the MRI measurements tracked this variability. Because of the large variation in the extent of LRNC and IPH between plaques, we chose to use the same length for x-and y-axes, but to vary the scale on these axes to reflect the different sizes of LRNC and IPH among plaques.
First, we compared the fat fractions and R2* values by MRI throughout all plaques inside and outside volumes of LRNC and IPH as identified by 3D histology. The average fat fraction by MRI was significantly higher inside LRNC than outside: 12.64 6 0.2737% versus 9.294 6 0.1762% (mean 6 SEM; P < 0.001). The same was true for IPH identified by 3D histology; R2* was significantly higher inside IPH than outside: 71.81 6 1.276 s À1 versus 56.94 6 0.9095 s À1 (mean 6 SEM; P < 0.001). As shown in Figure 6 , these differences persisted at the same level of significance for each individual patient. Next, we assessed the correlation between the cumulative fat fractions and R2* values from MRI and the volumes of LRNC and IPH from 3D histology. Taking together all values from all plaques, linear regression showed a strong correlation throughout all plaques between the cumulative fat fraction as measured in each voxel and the volume of LRNC from 3D histology (R 2 ¼ 0.92) as well as between the cumulative R2* per voxel and the volume of IPH (R 2 ¼ 0.94). These strong correlations were maintained at the level of the individual patient, as shown in Figure 7 . Figure 8 shows the mean difference and 95% limits of agreement between MRI and 3D histology.
DISCUSSION
Here, we show that plaque characteristics associated with a high risk of rupture and thrombosis can be quantified in vivo at high resolution by MRI. Moreover, we use 3D histology to validate in vivo carotid MRI, thus increasing the reliability of histology based validation of in vivo vascular imaging.
Through registration of T 1 W MRI with a four-point Dixon gradient-echo sequence, we were able to accurately map the fat fraction and the R2* value of each voxel to atherosclerotic plaques in the internal carotid artery. There was high variability among the plaques regarding the extent of LRNC and IPH, and the fact that we show strong correlations between MRI and 3D histology in all plaques speaks to the robustness and wide applicability of this technique.
As outlined earlier, a quantitative MRI method for measurement of the extent of LRNC has not been available. Regarding IPH, others have assessed the extent of IPH using a T2 mapping technique (23) . This technique was validated against multicontrast T 1 W, PDW and T 2 W carotid MRI, but histological validation was not reported. Moreover, T2 images were acquired using a spin-echo sequence, which precludes the acquisition of T2* and thus R2*. T2* relaxation was observed only with gradient-echo imaging because transverse relaxation caused by magnetic field inhomogeneities was eliminated by the 180 pulse at spin-echo imaging (24) . Importantly, the R2* value has a strong, linear correlation with (14) . Thus, we chose R2* for the quantification of the extent of IPH. More recently, quantitative T1 and T2 mapping has been proposed for plaque characterization, but these sequences were not validated against plaque histology; thus, it remains to be determined which plaque components are identified by this technique (25) . Others have indicated the need for the validation of in vivo imaging using 3D histology, and it has been used to optimize registration of carotid plaque histology to carotid MRI and computed tomography angiography in vivo (12, 26) . The improvements in registration offered by 3D histology come from its ability to account for tissue deformation during different tissue processing steps as well as the angulation differences between the specimen positioned vertically in a paraffin block and the in vivo image. The need to correct for tissue deformation is emphasized by the degree of expansion that we were able to calculate after the tissue sections had been registered to the 3D backbone generated from the en face images of the specimen. Furthermore, we were able to correct for shrinkage of the fresh specimen by registering the 3D volume to in vivo MRI, using the vessel lumen as a landmark. This was greatly facilitated by the blackblood sequence acquired during T 1 W imaging, which, owing to its high signal-to-noise ratio (SNR), allowed for accurate delineation of the vessel lumen. Moreover, the ability of 3D histology to support correction of the registration errors caused by angulation differences between the paraffin-embedded specimen plaque and in vivo MRI is illustrated by the fact that a small angulation error of 7 already results in a longitudinal displacement error of 0.6 mm (1 voxel) at a distance of 5 mm (12). The difficulties encountered in registration of 2D histology with 2D MRI slices are illustrated in Figure 5 , where we show that there was a partial mismatch between 2D histology and 2D MRI because the difference in angulation between histology sections and MRI could not be taken into account upon registration of 2D images. Importantly, here we advance the utility of 3D histology beyond its ability to optimize registration by generating 3D volumes from the stack that include volumes relevant to the assessment of atherosclerotic plaque vulnerability (i.e., the volumes of LRNC and IPH). This enabled us to add a quantitative dimension to the improved registration offered by 3D histology by comparing the voxel-wise measurement of fat and R2* to the volume of LRNC and IPH upon 3D histology.
Multicontrast MRI of carotid plaque has been used as a tool to assess stroke risk (7) . However, to date it has been difficult to connect MRI biomarkers of carotid angle to the vertical plane (see Fig. 4b ), resulting in a displacement error causing partial mismatch between 2D histology and 2D MRI as shown in the figure. An angulation error of 7 results in a displacement error of 0.6 mm (1 voxel) at a distance of 5 mm; thus, here this error amounted to almost two voxels at 5 mm (12) .
plaque vulnerability with the pathobiology of stroke and atherosclerotic plaque progression. There are numerous reasons for this lack of agreement between MRI and cerebrovascular ischemia as well as carotid plaque pathobiology. It cannot be ruled out, however, that the lack of specificity for LRNC and IPH of the sequences currently used in multicontrast plaque MRI, the nonquantitative nature of the approach, and its operator dependency have a detrimental effect on accuracy and reproducibility in longitudinal studies. This, in turn, may impact the analysis of the relationship between pathobiology and imaging biomarkers of plaque instability. Here, we present a single sequence that allows for direct in vivo quantitative, automated mapping of LRNC and IPH in carotid plaque. Importantly, the method correlates closely with the extent of LRNC and IPH in 3D histology over a wide range of volumes of LRNC and IPH. Because of its quantitative nature, this approach may be able to improve estimation of stroke and overall cardiovascular risk and elucidate the relationship between pathobiology and imaging biomarkers of plaque instability. Moreover, because of its relative simplicity and its use of automated voxel-based quantification of LRNC and IPH, it may prove to be particularly well suited for application in longitudinal studies.
A limitation inherent to the four-point Dixon method is its coarse modeling, where R2* differences, proton density differences, and T1 relaxation differences between water and fat are ignored. Moreover, the fat frequency peak is known to consist of multiple components, with a broad width, leading to an effective increased relaxation rate. These model assumptions were made because adding more degrees of freedom to the analysis would not be valid for a four-point measurement. Our goal was to develop a sequence that would be practical in routine patient care, thus a (relatively) short scan time and good repeatability for follow-up studies were important requirements. Therefore, we accepted a potential statistical offset for the water and fat fractions and other limitations inherent in the short scan time. Another limitation of our Dixon method is the T1 weighting attributed to the acquisition settings (TR ¼ 18 ms; flip angle ¼ 10 ). T1 weighting will suppress the water compartment more than the fat compartment, leading to an artificial enhancement of the fat content. This choice was made because of constraints regarding scan time and the SNR. If the T1 weighting were to be limited to <10% for both compartments, a TR >130 ms would be required, corresponding to a 7-fold increase in scan time. Given that the exact T1 relaxation is unknown, no attempt was made to correct for this effect. It is therefore reasonable to assume that the T1 weighting in the current protocol will contribute to an overestimation of the fat content. An additional, related effect is the B1 inhomogeneity, which may cause differences in T1 weighting throughout the volume. This effect, however, is expected to be small, considering the size of the acquisition volume and the moderate effect of B1 differences on saturation differences. Furthermore, the additional signal loss attributed to susceptibility differences over the imaging volume was ignored, potentially leading to an underestimation of R2*. However, in view of the very high R2* values found in hemorrhagic plaques with rates of over 50 s À1 , the effect of susceptibility is expected to be negligible.
Regarding registration of 3D histology with MRI, it is to be expected that the strong correlations reported here between MRI-based quantification of LRNC and IPH and 3D histology would be strengthened further if methods for nonrigid registration of MRI and 3D histology volumes had been available during the study. As expected, there are slight differences in the slopes of the regression lines shown in Figure 7 . In other words, there is a strong correlation between the volume of LRNC and IPH and fat and R2* by MRI within each patient, but there are differences between individual patients. This speaks to the strong heterogeneity in the composition of atherosclerotic plaques in general and the differences between patients in the current study. Even within areas designated as LRNC and IPH by their histological appearance, the tissue is heterogeneous (Fig. 2) and the fat and R2* values in one voxel may differ from those in adjacent , where all masked tissue was depicted in 3D as transparent gray. Fat values were superimposed with a yellow linear color ramp using a threshold of 5%. R2* values were superimposed with a red linear color ramp using a threshold of 50 s À1 . The red arrows show the orientation of the internal carotid artery from which the plaque was retrieved. The next column directly to the right shows 3D histology volume renderings of the atherosclerotic plaque (b,f,j,n,r). The orientation is identical to the internal carotid artery visualized from MRI. The LRNC volume is indicated in yellow and the IPH volume is indicated in red. The next two columns show correlation plots of the cumulative fat fraction (c,g,k,o,s) and the cumulative R2* value (d,h,l,p,t) within the plaque from the Dixon sequence against the volume of the LRNC and IPH from 3D histology. voxels. Furthermore, there are sources of fat and blood outside the LRNC and IPH, in the form of lipid laden macrophage foam cells and capillaries that are filled with blood (3). We would submit, however, that the strong correlations between 3D histology and MRI found for every patient speaks to the robustness of the MRI technique and that adequately powered prospective studies will help establish threshold fat and R2* values that predict carotid plaque rupture and ischemic cerebral events.
Finally, image artifacts attributed to patient motion constitute a major issue in carotid MRI and around 15% of all carotid MRI scans have unacceptable image quality (27) . In the current study, the MRI quality was not compromised by motion artifacts in 6 of 7 patients in whom we were able to acquire MRI; thus, our fail rate attributed to motion artifact is within the 15% reported by others. However, we acknowledge that our highresolution Dixon sequence, scanned without a dedicated carotid coil, has a relatively low SNR. In future studies, we anticipate that the use of a dedicated carotid coil will increase the SNR and reduce the fail rate. Unfortunately, we did not have access to such a coil during the present study. The increased SNR could allow for reductions in scan time through use of higher parallel imaging factors. In view of the long scan time and the small voxel size in the current imaging protocol, we would not use additional SNR to reduce voxel size. Furthermore, the present study did not use motion rejection techniques. Our 3D acquisition is relatively insensitive to pulsatile motion given that the k-space readout occurs in a radial lowhigh fashion. If a number of k-space lines display a different signal intensity attributed to blood flow, for example, the effect will, after Fourier transform, be spread out as radial streaking artifacts over the entire image, and not, as in the linear Cartesian case, as a band centered at the vessel. Bulk motion, however, disrupts the imaging, as exemplified in the one case that was excluded. Techniques that reject data acquired during swallowing, such as free-induction decay navigators, could be applied in the future to reduce the fail rate (28) .
CONCLUSIONS
In conclusion, we present a quantitative mapping technique for atherosclerotic LRNC and IPH, which relies on direct measurement of fat-and iron-sensitive imaging. Moreover, we have validated this technique thoroughly using 3D histology. The quantitative nature of this technique should facilitate the interrogation of the relationship between MRI biomarkers of carotid plaque vulnerability, atherosclerotic plaque progression, and stroke from carotid plaque. Its reliance on a single sequence and the automated nature of the quantification should facilitate transferability between scanners and assessment of changes in LRNC and IPH in longitudinal studies.
FIG. 8. Bland-Altman plots showing the mean difference and the 95% limits of agreement between MRI and 3D histology. The upper row (a-e) shows the mean difference and 95% limits of agreement for cumulative fat fraction from Dixon imaging and the volume of lipid rich necrotic core from 3D histology. The lower row shows the same for the cumulative R2* value and the volume of IPH (f-j). As is apparent from Figure 7 , the difference between the methods increases as the magnitude of the measured values increases. As recommended by Bland and Altman, this approximate proportionality between difference and magnitude of the measurements was addressed by plotting the ratio of the MRI values versus the 3D histology values as a function of their average (21) .
